Natural history of vertically acquired HCV infection and associated autoimmune phenomena
- PMID: 24585099
- DOI: 10.1007/s00431-014-2286-6
Natural history of vertically acquired HCV infection and associated autoimmune phenomena
Abstract
The natural history of vertically acquired HCV infection is ill defined. The aim of this study was to outline the natural course of vertical HCV infection in a cohort of untreated children, including rate of spontaneous viral clearance, frequency and features of HCV-related autoimmune disorders. Children with vertical HCV infection were prospectively followed from the first month of life with regular clinical and laboratory assessments. Statistical analysis was performed using Prism 5.0. Forty-five children (median age 12 years, interquartile range 6.9-15.5) were studied. Genotype 1 was predominant (53.3 %). Spontaneous viral clearance was achieved by 12 patients (26.7 %) and associated with genotype 3. Alanine-amino-transferase levels were increased in most children in the first 2 years of life with higher values in those who later cleared the infection. All children were asymptomatic for liver disease. Transient elastography (32 patients) showed mild or moderate fibrosis in nine and two cases, respectively. Non-organ-specific autoantibodies were detected in 24 children (53.3 %) independently of viremia; of these, one developed type-1 diabetes. Cryoglobulinemia was associated with genotype 1 infection and found in 15 subjects (33.3 %): two had low C4 levels and persistent proteinuria.
Conclusions: Vertically acquired HCV infection may result in spontaneous clearance in up to 27 % of children. Resolution of infection is higher with genotype 3, usually occurs in preschool age and persists over time. Chronic infection is generally asymptomatic, although hepatomegaly and mild fibrosis may develop. Autoantibodies and cryoglobulins are frequent, whereas the associated clinical manifestations are rare.
Similar articles
-
A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.Hepatogastroenterology. 1997 Mar-Apr;44(14):417-25. Hepatogastroenterology. 1997. PMID: 9164512
-
Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progression.World J Gastroenterol. 2016 Jan 28;22(4):1382-92. doi: 10.3748/wjg.v22.i4.1382. World J Gastroenterol. 2016. PMID: 26819507 Free PMC article. Review.
-
Persistence rate and progression of vertically acquired hepatitis C infection. European Paediatric Hepatitis C Virus Infection.J Infect Dis. 2000 Feb;181(2):419-24. doi: 10.1086/315264. J Infect Dis. 2000. PMID: 10669321
-
Three broad modalities in the natural history of vertically acquired hepatitis C virus infection.Clin Infect Dis. 2005 Jul 1;41(1):45-51. doi: 10.1086/430601. Epub 2005 May 24. Clin Infect Dis. 2005. PMID: 15937762
-
Long-term outcome of vertically acquired and post-transfusion hepatitis C infection in children.J Gastroenterol Hepatol. 2004 Dec;19(12):1357-62. doi: 10.1111/j.1440-1746.2004.03463.x. J Gastroenterol Hepatol. 2004. PMID: 15610308 Review.
Cited by
-
Update on Pediatric Hepatitis C Infection.Curr Gastroenterol Rep. 2025 Feb 28;27(1):18. doi: 10.1007/s11894-024-00955-3. Curr Gastroenterol Rep. 2025. PMID: 40019674 Free PMC article. Review.
-
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.Hepatology. 2020 Feb;71(2):686-721. doi: 10.1002/hep.31060. Hepatology. 2020. PMID: 31816111 Free PMC article. No abstract available.
-
Three Children Treated with Direct-acting Antivirals for Chronic Hepatitis C Virus Genotype 1b Infection.Intern Med. 2020 Apr 1;59(7):941-944. doi: 10.2169/internalmedicine.3824-19. Epub 2019 Dec 6. Intern Med. 2020. PMID: 31813916 Free PMC article.
-
Hepatitis C virus infection in children and adolescents.Hepatol Commun. 2017 Mar 23;1(2):87-98. doi: 10.1002/hep4.1028. eCollection 2017 Apr. Hepatol Commun. 2017. PMID: 29404447 Free PMC article. Review. No abstract available.
-
Treatment of hepatitis C in children and adolescents: how far have we reached?World J Pediatr. 2023 Feb;19(2):107-119. doi: 10.1007/s12519-022-00612-7. Epub 2022 Sep 21. World J Pediatr. 2023. PMID: 36129634 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous